LTQA Comments on Medicare Advantage and Part D Proposed Rule

On March 7, 2022, LTQA submitted comments on the Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs proposed rule. LTQA appreciates CMS’ efforts to support MA beneficiaries with serious, chronic conditions and functional needs through this Proposed Rule. In our comments, we highlight several considerations on the provisions with … Read More